Here’s an interview with researcher Albert Garcia-Romeu, where he discusses the potential of psilocybin to address issues associated with cognitive decline, and noteworthy preliminary observations from his research.
Read morePsychedelics, Alzheimer’s Disease and Related Dementias
Psychedelics may have a role in treating Alzheimer’s disease and related dementias.
Read the latest research insights and treatment approaches.
Read moreLSD and Alzheimer's
Microdosing LSD for Alzheimer’s proves safe in early human trial.
Read morePsilocybin Being Researched As Aid for Alzheimer's and Depression
The largest psychedelic research center in the world, and the first of its kind in the United States, will open at Johns Hopkins Medicine in Maryland. Funded by $17 million from private donors, the Center for Psychedelic and Consciousness Research will conduct research into the use of psychedelic drugs in the treatment of addiction, PTSD, depression, Alzheimer's disease and more.
Read more